Evidence map›Paper›PMID 33393500›Full record

ArticleThe Journal of clinical investigation2021

Human skin is colonized by T cells that recognize CD1a independently of lipid.

Rachel N Cotton, Tan-Yun Cheng, Marcin Wegrecki, Jérôme Le Nours, Dennis P Orgill, Bohdan Pomahac, Simon G Talbot, Richard A Willis, John D Altman, Annemieke de Jong and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. CD1a and Lipids as Mediators of T Cell Activation in the Skin.The Journal of investigative dermatology · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. CD1 displays its own negative regulators.Current opinion in immunology · 2023
    Review
  12. Group AScience immunology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Revisiting the Experimental Methods for Human Skin T-Cell Analysis.JID innovations : skin science from molecules to population health · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Rachel N CottonGraduate Program in Immunology, Harvard Medical School, Boston, Massachusetts, USA.
Tan-Yun ChengDivision of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Marcin WegreckiInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Jérôme Le NoursInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Dennis P OrgillDivision of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston Massachusetts, USA.
Bohdan PomahacDivision of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston Massachusetts, USA.
Simon G TalbotDivision of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston Massachusetts, USA.
Richard A WillisNIH Tetramer Core Facility, Emory University, Atlanta, Georgia, USA.
John D AltmanNIH Tetramer Core Facility, Emory University, Atlanta, Georgia, USA.
Annemieke de JongDepartment of Dermatology, Columbia University Irving Medical Center, New York, New York, USA.
Graham OggMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Ildiko Van RhijnDivision of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jamie RossjohnInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Rachael A ClarkDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
D Branch MoodyDivision of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Brigham and Women's Hospital · USAustralian Research Council · AUEmory University · USColumbia University Irving Medical Center · USMRC Human Immunology Unit · GB

Funding

MECHANISMS OF ARTHRITIC &DERMATOLOGY DISORDERST32AR007530 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Michael B. Brenner, Ellen M Gravallese · 1986 to 2026
$10.4M
CD1 Presentation of Self Lipids to Human T CellsR01AR048632 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2002 to 2024
$9.4M
The Next Generation Immunoanalysis CoreP30AR069625 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2016 to 2025
$8.8M
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin VaccinationR01AI127654 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN, KUPPER, THOMAS S. · 2017 to 2021
$6.0M
Translational and Precision Medicine Resources Core (TRAP)P30AR069632 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI OWENS, DAVID M · 2016 to 2020
$3.9M
Role of secreted phospholipase A2 in the activation of human CD1-restricted T cellsR01AR074037 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE JONG, ANNEMIEKE · 2019 to 2024
$1.7M
CD1 autoreactive T cells in human inflammatory skin diseaseR37AR048632 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI DAVID Branch MOODY · 2025 to 2026
$1.1M
Activation of Human Skin T Cells by Mammalian and Microbial Lipids Presented by CD1aK01AR068475 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE JONG, ANNEMIEKE · 2015 to 2019
$541k
Department of HealthMedical Research Council MC_EX_MR/R022550/1Medical Research Council MC_UU_00008/5NIAID NIH HHS R01 AI127654NIAMS NIH HHS K01 AR068475NIAMS NIH HHS P30 AR069625NIAMS NIH HHS P30 AR069632NIAMS NIH HHS R01 AR048632NIAMS NIH HHS R01 AR074037NIAMS NIH HHS R37 AR048632NIAMS NIH HHS T32 AR007530Wellcome Trust 209222/Z/17/Z
6 · The paper itself

Abstract

CD1a-autoreactive T cells contribute to skin disease, but the identity of immunodominant self-lipid antigens and their mode of recognition are not yet solved. In most models, MHC and CD1 proteins serve as display platforms for smaller antigens. Here, we showed that CD1a tetramers without added antigen stained large T cell pools in every subject tested, accounting for approximately 1% of skin T cells. The mechanism of tetramer binding to T cells did not require any defined antigen. Binding occurred with approximately 100 lipid ligands carried by CD1a proteins, but could be tuned upward or downward with certain natural self-lipids. TCR recognition mapped to the outer A' roof of CD1a at sites remote from the antigen exit portal, explaining how TCRs can bind CD1a rather than carried lipids. Thus, a major antigenic target of CD1a T cell autoreactivity in vivo is CD1a itself. Based on their high frequency and prevalence among donors, we conclude that CD1a-specific, lipid-independent T cells are a normal component of the human skin T cell repertoire. Bypassing the need to select antigens and effector molecules, CD1a tetramers represent a simple method to track such CD1a-specific T cells from tissues and in any clinical disease.

Indexed as

Antigens, CD1HEK293 CellsHumansK562 CellsMembrane LipidsReceptors, Antigen, T-CellSkinT-LymphocytesAntigens, CD1CD1a antigenMembrane LipidsReceptors, Antigen, T-CellAntigen presentationDermatologyImmunologySkinT cells

Identifiers

PMID33393500
PMCPMC7773353
OpenAlexW3118648290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.